Fortress Biotech (FBIO) Cut to Sell at Zacks Investment Research

Fortress Biotech (FBIO) Cut to Sell at Zacks Investment Research


According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога